BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22641268)

  • 1. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
    Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
    Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triazole-linked transition state analogs as selective inhibitors against V. cholerae sialidase.
    Slack TJ; Li W; Shi D; McArthur JB; Zhao G; Li Y; Xiao A; Khedri Z; Yu H; Liu Y; Chen X
    Bioorg Med Chem; 2018 Nov; 26(21):5751-5757. PubMed ID: 30389408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.
    Li Y; Cao H; Yu H; Chen Y; Lau K; Qu J; Thon V; Sugiarto G; Chen X
    Mol Biosyst; 2011 Apr; 7(4):1060-72. PubMed ID: 21206954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
    Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
    Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity in influenza virus targeted drug design: interaction with human sialidases.
    Chavas LM; Kato R; Suzuki N; von Itzstein M; Mann MC; Thomson RJ; Dyason JC; McKimm-Breschkin J; Fusi P; Tringali C; Venerando B; Tettamanti G; Monti E; Wakatsuki S
    J Med Chem; 2010 Apr; 53(7):2998-3002. PubMed ID: 20222714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
    Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
    J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases.
    Birikaki L; Pradeau S; Armand S; Priem B; Márquez-Domínguez L; Reyes-Leyva J; Santos-López G; Samain E; Driguez H; Fort S
    Chemistry; 2015 Jul; 21(30):10903-12. PubMed ID: 26088695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.
    Zhang Y; Albohy A; Zou Y; Smutova V; Pshezhetsky AV; Cairo CW
    J Med Chem; 2013 Apr; 56(7):2948-58. PubMed ID: 23530623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase.
    Haselhorst T; Wilson JC; Thomson RJ; McAtamney S; Menting JG; Coppel RL; von Itzstein M
    Proteins; 2004 Aug; 56(2):346-53. PubMed ID: 15211517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.
    Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE
    Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insight into substrate recognition by human cytosolic sialidase NEU2.
    Mozzi A; Mazzacuva P; Zampella G; Forcella ME; Fusi PA; Monti E
    Proteins; 2012 Apr; 80(4):1123-32. PubMed ID: 22228546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of delta4-beta-D-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition.
    Florio P; Thomson RJ; Alafaci A; Abo S; von Itzstein M
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2065-8. PubMed ID: 10450982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the human cytosolic sialidase Neu2. Evidence for the dynamic nature of substrate recognition.
    Chavas LM; Tringali C; Fusi P; Venerando B; Tettamanti G; Kato R; Monti E; Wakatsuki S
    J Biol Chem; 2005 Jan; 280(1):469-75. PubMed ID: 15501818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility.
    Rudrawar S; Kerry PS; Rameix-Welti MA; Maggioni A; Dyason JC; Rose FJ; van der Werf S; Thomson RJ; Naffakh N; Russell RJ; von Itzstein M
    Org Biomol Chem; 2012 Nov; 10(43):8628-39. PubMed ID: 22976385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects and specificity of synthetic sialyldendrimers toward recombinant human cytosolic sialidase 2 (NEU2).
    Rahman MM; Kitao S; Tsuji D; Suzuki K; Sakamoto J; Matsuoka K; Matsuzawa F; Aikawa S; Itoh K
    Glycobiology; 2013 Apr; 23(4):495-504. PubMed ID: 23363739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple synthesis of N-perfluoroacylated and N-acylated glycals of neuraminic acid with a cyclic aminic substituent at the 4α position as possible inhibitors of sialidases.
    Rota P; Allevi P; Agnolin IS; Mattina R; Papini N; Anastasia M
    Org Biomol Chem; 2012 Apr; 10(14):2885-94. PubMed ID: 22395901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-Azido-9-deoxy-2,3-difluorosialic Acid as a Subnanomolar Inhibitor against Bacterial Sialidases.
    Li W; Santra A; Yu H; Slack TJ; Muthana MM; Shi D; Liu Y; Chen X
    J Org Chem; 2019 Jun; 84(11):6697-6708. PubMed ID: 31083938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique sialidase that cleaves the Neu5Gcalpha2-->5-O(glycolyl)Neu5Gc linkage: comparison of its specificity with that of three microbial sialidases toward four sialic acid dimers.
    Inoue S; Lin SL; Inoue Y; Groves DR; Thomson RJ; von Itzstein M; Pavlova NV; Li SC; Li YT
    Biochem Biophys Res Commun; 2001 Jan; 280(1):104-9. PubMed ID: 11162485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy for neuraminidase inhibitors using mechanism-based labeling information.
    Hinou H; Miyoshi R; Takasu Y; Kai H; Kurogochi M; Arioka S; Gao XD; Miura N; Fujitani N; Omoto S; Yoshinaga T; Fujiwara T; Noshi T; Togame H; Takemoto H; Nishimura S
    Chem Asian J; 2011 Apr; 6(4):1048-56. PubMed ID: 21305698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase.
    Mann MC; Thomson RJ; Dyason JC; McAtamney S; von Itzstein M
    Bioorg Med Chem; 2006 Mar; 14(5):1518-37. PubMed ID: 16275104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.